Sinphar Pharmaceutical Co.,Ltd. (TPE:1734)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
32.50
+0.05 (0.15%)
Aug 26, 2026, 1:30 PM CST

Sinphar Pharmaceutical Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
351.67365.75304.71375.17224.64-38.14
Depreciation & Amortization
244.66241.61243.47230.04248.7247.33
Other Amortization
12.7212.7213.913.4918.0122.04
Loss (Gain) From Sale of Assets
0.841.052.48-5.130.811.5
Loss (Gain) From Sale of Investments
-0.1-0.12-0.3---
Provision & Write-off of Bad Debts
0.1-0.141.680.472.54
Other Operating Activities
-2.08-5.87-3.62-187.15-26.55-190.8
Change in Accounts Receivable
-18.89-80.44-17.727.29-73.59-84.1
Change in Inventory
-84.17-9.78124.29-102.18-39.62-15.95
Change in Accounts Payable
17.8325.13-106-31.97121.927.05
Change in Unearned Revenue
-6.315.9311.77-10.912.92-4.16
Change in Other Net Operating Assets
82.0328.6720.37-13.95-52.42188.24
Operating Cash Flow
598.31584.66593.51296.37425.3135.54
Operating Cash Flow Growth
5.23%-1.49%100.26%-30.31%213.77%-7.41%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-266.51-194.71-240.44-295.51-141.48-146.18
Sale of Property, Plant & Equipment
0.070.050.486.30.240.53
Sale (Purchase) of Intangibles
-12.74-6.24-16.28-5.43-11.96-15.26
Investment in Securities
14.88-29.35-136.62-2.4533.760.33
Other Investing Activities
4.375.621.77-37.48-4.8-45.02
Investing Cash Flow
-259.92-224.63-391.08-334.56-124.24-205.6

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-----35
Long-Term Debt Issued
--5016018085
Total Debt Issued
560-50160180120
Short-Term Debt Repaid
--182-30-47-140-
Long-Term Debt Repaid
--211.89-62.36-81.1-259.07-138.92
Total Debt Repaid
-182.63-393.89-92.36-128.1-399.07-138.92
Net Debt Issued (Repaid)
377.37-393.89-42.3631.9-219.07-18.92
Issuance of Common Stock
-----15.58
Common Dividends Paid
-181.14-181.14-167.72-167.72-33.54-33.54
Other Financing Activities
-0.99-1115.15-10.72159.83
Financing Cash Flow
195.24-576.03-209.08-120.67-263.33122.95

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
52.524.467.83-4.25.04-1.88
Net Cash Flow
586.15-211.531.18-163.0742.7751.02

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
331.81389.95353.080.86283.82-10.64
Free Cash Flow Growth
-18.43%10.45%40955.23%-99.70%--
Free Cash Flow Margin
9.62%11.57%11.21%0.03%9.93%-0.44%
Free Cash Flow Per Share
1.742.041.850.011.49-0.06
Levered Free Cash Flow
252.54279.33232.08-125.83206.6165.95
Unlevered Free Cash Flow
272.79300.48255.06-104.76223.9981.45

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
31.9534.1536.4933.6527.6424.86
Cash Income Tax Paid
57.1341.915.357.3747.144.35
Change in Working Capital
-9.51-30.4932.73-131.73-40.7991.08